Immunovant Inc (NASDAQ:IMVT) price on current trading day, rose 4.10% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $19.66.
A look at the stock’s price movement, the level at last check in today’s session was $18.88, moving within a range at $18.51 and $19.693. The beta value (5-Year monthly) was 0.676. Turning to its 52-week performance, $35.97 and $17.01 were the 52-week high and 52-week low respectively. Overall, IMVT moved -5.60% over the past month.
Immunovant Inc’s market cap currently stands at around $3.34 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-29.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IMVT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
20 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 6 analyst(s) rate the stock as a Hold, 13 recommend IMVT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IMVT’s current price about 0.03% and -6.50% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.61, while 7-day volatility ratio is 8.09% and 5.84% in the 30-day chart. Further, Immunovant Inc (IMVT) has a beta value of 0.76, and an average true range (ATR) of 1.21. Analysts have given the company’s stock an average 52-week price target of $49, forecast between a low of $5 and high of $57. Looking at the price targets, the low is 74.57% off recent price level in today’s trading while to achieve the yearly target high, it has to move -189.93%. Nonetheless, investors will most likely welcome a -149.24% jump to $49 which is the analysts’ median price.
If we refocus on Immunovant Inc (NASDAQ:IMVT), historical trading data shows that trading volumes averaged 1.88 over the past 10 days and 1.35 million over the past 3 months. The company’s latest data on shares outstanding shows there are 147.20 million shares.
The 59.16% of Immunovant Inc’s shares are in the hands of company insiders while institutional holders own 47.38% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 15.39 million on 2025-02-28, giving us a short ratio of 11.25. The data shows that as of 2025-02-28 short interest in Immunovant Inc (IMVT) stood at 1759.0 of shares outstanding, with shares short rising to 13.15 million registered in 2025-01-31. Current price change has pushed the stock -20.65% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IMVT stock continues to rise going into the next quarter.
